Shutting the back door to prostate cancer
Posted on: Sunday, November 15th, 2026
Weizmann Institute Professor Yosef Yarden has discovered how to stop prostate cancer returning after initial treatment to cut off testosterone. He used an already approved medication, relacorilant, to shut the cortisol backdoor pathway. Clinical tests are now in progress.
https://sharingfromisrael.substack.com/p/a-professor-in-israel-found-out-why
https://www.pcf.org/find-prostate-cancer-trials/a-study-of-enzalutamide-plus-the-glucocorticoid-receptor-antagonist-relacorilant-versus-placebo-for-patients-with-high-risk-localized-prostate-cancer/
This entry was posted in
Israel's Medical Achievements. Bookmark the
permalink.